Diabetes Type 2

Type 2 Diabetes and Medication Adherence: Where is the Disconnect?

Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?

Diabetes Type 2

Premixed insulin--a basal and prandial product delivered in one injection--sounds like an ideal solution for patients who resist multidose insulin therapy. For some it is, but not for all. A case and the caveats, here.

There are 2 FDA-approved sodium-glucose contransporter-2 inhibitors available in the United States. Here, a concise review of advantages/disadvantages and considerations in patient selection.

Patients with NAFLD are at high risk for development of type 2 diabetes and those with diabetes may be at higher risk of dying from NALFD-associated chronic liver disease. Here, options for prevention and treatment.

A systematized, team-based approach to type 2 diabetes management really can reduce vascular complications. In this study, by the Geisinger Health System, it took just 3 years.

Conventional wisdom holds that eating more frequent and smaller meals is healthier than the traditional 3 squares. But, a new study finds that fewer and larger may be better for glycemic control in patients with type 2 diabetes.

Improvement in overall diet quality lowers the risk of type 2 diabetes, a new study shows. This is independent of other healthful behaviors, including increased physical activity and body weight loss.

New guidelines for the treatment of patients with high cholesterol may, or may not, be appropriate for persons with type 2 diabetes. Here are the pros and cons.


Subscribe to Diabetes Type 2 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.